NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies:
- Albireo (NASDAQ: ALBO)
Albireo has agreed to merge with Ipsen. Under the proposed transaction, Albireo shareholders will receive $42.00 in cash plus a contingent value right of $10.00 per share.
- Leap Therapeutics, Inc. (NASDAQ: LPTX)
Leap Therapeutics has agreed to merge with Flame Biosciences. Under the proposed transaction, Leap Therapeutics will issue approximately 19,794,373 shares of its common stock and approximately 136,833 shares of a newly designated Series X non-voting convertible preferred stock to Flame stockholders.
- AlerisLife Inc. (NASDAQ: ALR)
AlerisLife has agreed to merge with ABP Acquisition LLC. Under the proposed transaction, AlerisLife shareholders will receive $1.31 per share in cash.
- Chembio Diagnostics, Inc. (NASDAQ: CEMI)
Chembio Diagnostics has agreed to merge with Biosynex SA. Under the proposed transaction, Chembio shareholders will receive $0.45 per share in cash.
Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process.
Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com. The consultation and case are free with no obligation to you. Moore Kuehn pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please visit http://www.moorekuehn.com/practice/new-york-securities-litigation/.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
jkuehn@moorekuehn.com
(212) 709-8245
